Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1140)
MediWound Ltd. (MDWD)
SHAMIR NACHUM — Director
Shares
175
Price
$13.97
Total Value
$2.45K
Shares Held After
49,990
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
142
Price
$551.97
Total Value
$78.38K
Shares Held After
40,513
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$551.23
Total Value
$44.10K
Shares Held After
40,655
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
842
Price
$550.06
Total Value
$463.15K
Shares Held After
40,735
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,956
Price
$549.15
Total Value
$1.07M
Shares Held After
41,577
% of Holdings
4.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,226
Price
$548.04
Total Value
$1.22M
Shares Held After
43,533
% of Holdings
4.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,664
Price
$546.96
Total Value
$910.14K
Shares Held After
45,759
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,050
Price
$546.01
Total Value
$573.31K
Shares Held After
47,423
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,139
Price
$545.22
Total Value
$621.01K
Shares Held After
48,473
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
401
Price
$543.89
Total Value
$218.10K
Shares Held After
49,612
% of Holdings
0.8%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Bumpus Namandje — Director
Shares
4,386
Price
$3.54
Total Value
$15.53K
Shares Held After
43,171
% of Holdings
9.2%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
15,000
Price
$10.76
Total Value
$161.36K
Shares Held After
147,680
% of Holdings
9.2%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
17,500
Price
$10.90
Total Value
$190.76K
Shares Held After
162,680
% of Holdings
9.7%
Spyre Therapeutics, Inc. (SYRE)
Sloan Sheldon — Chief Medical Officer
Shares
8,333
Price
$75.00
Total Value
$624.98K
Shares Held After
0
% of Holdings
100.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
6,100
Price
$69.69
Total Value
$425.12K
Shares Held After
767,780
% of Holdings
0.8%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
2,000
Price
$68.74
Total Value
$137.47K
Shares Held After
773,880
% of Holdings
0.3%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
1,500
Price
$67.67
Total Value
$101.51K
Shares Held After
775,880
% of Holdings
0.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
400
Price
$66.37
Total Value
$26.55K
Shares Held After
777,380
% of Holdings
0.1%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
29,749
Price
$0.42
Total Value
$12.49K
Shares Held After
482,776
% of Holdings
5.8%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Saxena Nishant C — Chief Business Officer
Shares
9,000
Price
$7.58
Total Value
$68.22K
Shares Held After
75,300
% of Holdings
12.0%
Alector, Inc. (ALEC)
Wong-Sarad Grace — Principal Accounting Officer
Shares
3,475
Price
$1.88
Total Value
$6.54K
Shares Held After
95,461
% of Holdings
3.5%
Liquidia Corp (LQDA)
KIRSCH ARTHUR S — Director
Shares
10,000
Price
$54.80
Total Value
$548.00K
Shares Held After
0
% of Holdings
100.0%
Janux Therapeutics, Inc. (JANX)
Doyle Janeen Noel — Chief Corp. & Bus. Dev. Ofcr
Shares
4,059
Price
$14.03
Total Value
$56.94K
Shares Held After
75,941
% of Holdings
5.1%
Vericel Corp (VCEL)
Hopper Jonathan Mark — Chief Medical Officer
Shares
4,375
Price
$35.00
Total Value
$153.12K
Shares Held After
75,753
% of Holdings
5.5%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
20,000
Price
$70.60
Total Value
$1.41M
Shares Held After
3,985
% of Holdings
83.4%
Nautilus Biotechnology, Inc. (NAUT)
AH Equity Partners Bio II, L.L.C. — 10% Owner
Shares
384,026
Price
$2.35
Total Value
$902.46K
Shares Held After
971,885
% of Holdings
28.3%
Nautilus Biotechnology, Inc. (NAUT)
AH Equity Partners Bio II, L.L.C. — 10% Owner
Shares
4,615,974
Price
$2.35
Total Value
$10.85M
Shares Held After
11,682,032
% of Holdings
28.3%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Borgeson Blake — Director
Shares
30,000
Price
$3.68
Total Value
$110.40K
Shares Held After
6,169,863
% of Holdings
0.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
3,400
Price
$66.75
Total Value
$226.93K
Shares Held After
767,780
% of Holdings
0.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
16,600
Price
$66.31
Total Value
$1.10M
Shares Held After
771,180
% of Holdings
2.1%
Fortrea Holdings Inc. (FTRE)
Mcconnell Jill G. — Chief Financial Officer
Shares
4,866
Price
$15.49
Total Value
$75.37K
Shares Held After
78,416
% of Holdings
5.8%
Fortrea Holdings Inc. (FTRE)
Morais Mark A. — Chief Operating Officer
Shares
4,866
Price
$15.49
Total Value
$75.37K
Shares Held After
76,039
% of Holdings
6.0%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
29,595
Price
$0.45
Total Value
$13.32K
Shares Held After
512,525
% of Holdings
5.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$543.26
Total Value
$152.11K
Shares Held After
40,513
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$541.68
Total Value
$238.34K
Shares Held After
40,793
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
641
Price
$540.48
Total Value
$346.45K
Shares Held After
41,233
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,310
Price
$539.83
Total Value
$1.25M
Shares Held After
41,874
% of Holdings
5.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,149
Price
$538.81
Total Value
$619.09K
Shares Held After
44,184
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,464
Price
$537.62
Total Value
$787.08K
Shares Held After
45,333
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,056
Price
$536.62
Total Value
$1.10M
Shares Held After
46,797
% of Holdings
4.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,160
Price
$535.69
Total Value
$621.40K
Shares Held After
48,853
% of Holdings
2.3%
Outlook Therapeutics, Inc. (OTLK)
Haddadin Yezan Munther — Director
Shares
29,000
Price
$0.83
Total Value
$24.15K
Shares Held After
66,167
% of Holdings
43.8%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Saxena Nishant C — Chief Business Officer
Shares
4,500
Price
$7.33
Total Value
$33.00K
Shares Held After
66,300
% of Holdings
6.8%
Alector, Inc. (ALEC)
Berkley Neil Lindsay — CFO & Chief Business Officer
Shares
19,360
Price
$1.97
Total Value
$38.22K
Shares Held After
379,900
% of Holdings
4.8%
Alector, Inc. (ALEC)
Wong-Sarad Grace — Principal Accounting Officer
Shares
5,709
Price
$1.97
Total Value
$11.27K
Shares Held After
98,936
% of Holdings
5.5%
Alector, Inc. (ALEC)
Rosenthal Arnon — Director
Shares
87,216
Price
$1.97
Total Value
$172.19K
Shares Held After
2,367,206
% of Holdings
3.6%
Liquidia Corp (LQDA)
KIRSCH ARTHUR S — Director
Shares
5,000
Price
$56.00
Total Value
$280.00K
Shares Held After
10,000
% of Holdings
33.3%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
50,000
Price
$9.43
Total Value
$471.30K
Shares Held After
886,000
% of Holdings
5.6%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
206,005
Price
$15.28
Total Value
$3.15M
Shares Held After
13,044,106
% of Holdings
1.6%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
349
Price
$4.46
Total Value
$1.56K
Shares Held After
181,509
% of Holdings
0.2%
Showing 101–150 of 1140 transactions (page 3 of 23)